Correction: Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort.

Correction: Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort.

[This corrects the article DOI: 10.1371/journal.pone.0238091.].

Bibliographic Details
Main Authors:	Ross McQueenie, Hamish M E Foster, Bhautesh D Jani, Srinivasa Vittal Katikireddi, Naveed Sattar, Jill P Pell, Frederick K Ho, Claire L Niedzwiedz, Claire E Hastie, Jana Anderson, Patrick B Mark, Michael Sullivan, Catherine A O'Donnell, Frances S Mair, Barbara I Nicholl
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2021-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0251613

Similar Items

Association between childhood maltreatment and the prevalence and complexity of multimorbidity: A cross-sectional analysis of 157,357 UK Biobank participants
by: Peter Hanlon, et al.
Published: (2020-07-01)

Patterns of multimorbidity and their effects on adverse outcomes in rheumatoid arthritis: a study of 5658 UK Biobank participants
by: Stefan Siebert, et al.
Published: (2020-11-01)

Long-term conditions, multimorbidity and colorectal cancer risk in the UK Biobank cohort
by: Neave ME Corcoran, et al.
Published: (2022-06-01)

Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants
by: Peter Hanlon, MSc, et al.
Published: (2018-07-01)

Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies.
by: Peter Hanlon, et al.
Published: (2022-03-01)

Emerging trends and future research on the role of socioeconomic status in chronic illness and multimorbidity
by: Frances S Mair, et al.
Published: (2020-03-01)

Social connection and mortality in UK Biobank: a prospective cohort analysis
by: Hamish M. E. Foster, et al.
Published: (2023-11-01)

Examining the relationship between rheumatoid arthritis, multimorbidity and adverse health-related outcomes: A systematic review protocol
by: Jordan Canning, et al.
Published: (2020-03-01)

Multimorbidity and the COVID-19 pandemic – An urgent call to action
by: Frances S Mair, et al.
Published: (2020-10-01)

Associations between long-term conditions and upper gastrointestinal cancer incidence: A prospective population-based cohort of UK Biobank participants
by: Jennifer Marley, et al.
Published: (2021-11-01)

Modifiable and non-modifiable risk factors for COVID-19, and comparison to risk factors for influenza and pneumonia: results from a UK Biobank prospective cohort study
by: Naveed Sattar, et al.
Published: (2020-11-01)

Frailty in COPD: an analysis of prevalence and clinical impact using UK Biobank
by: Jennifer K Quint, et al.
Published: (2022-07-01)

Associations between multimorbidity and glycaemia (HbA1c) in people with type 2 diabetes: cross-sectional study in Australian general practice
by: Jo-Anne Manski-Nankervis, et al.
Published: (2020-11-01)

An observational analysis of frailty in combination with loneliness or social isolation and their association with socioeconomic deprivation, hospitalisation and mortality among UK Biobank participants
by: Marina Politis, et al.
Published: (2024-03-01)

Frailty in rheumatoid arthritis and its relationship with disease activity, hospitalisation and mortality: a longitudinal analysis of the Scottish Early Rheumatoid Arthritis cohort and UK Biobank
by: Stefan Siebert, et al.
Published: (2022-03-01)

Polypharmacy Management in Elderly Patients with Multimorbidity
by: Wanyu PAN, Chunhui ZHANG, Zhenxiang ZHANG, Jing CHEN, Yongxia MEI, Beilei LIN, Shaoyang WANG, Qinghua ZHAI
Published: (2022-05-01)

Comorbidity versus multimorbidity: Why it matters
by: Christopher Harrison, et al.
Published: (2021-02-01)

Psychological distress among people with probable COVID-19 infection: analysis of the UK Household Longitudinal Study
by: Claire L. Niedzwiedz, et al.
Published: (2021-05-01)

Multimorbidity or Polypharmacy: Two Sides of the Same Coin?
by: Carol Sinnott, et al.
Published: (2015-01-01)

Multimorbidity and Blood Pressure Control in Patients Attending Primary Care in Canada
by: Tu N. Nguyen, et al.
Published: (2023-12-01)

Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority
by: Claire L. Niedzwiedz, et al.
Published: (2019-10-01)

MULTIMORBID AND POLYPHARMACY IN CLINICAL CARDIOLOGY IN TERMS OF THE CLINICAL CASE
by: A. O. Radchenko, et al.
Published: (2017-06-01)

Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: A prospective cohort study in the UK Biobank
by: Frederick K Ho, et al.
Published: (2022-06-01)

The contribution of risk factors to socioeconomic inequalities in multimorbidity across the lifecourse: a longitudinal analysis of the Twenty-07 cohort
by: Srinivasa Vittal Katikireddi, et al.
Published: (2017-08-01)

The association of anxiety and stress-related disorders with C-reactive protein (CRP) within UK Biobank
by: Emma Kennedy, et al.
Published: (2022-02-01)

Multimorbidity, mortality, and HbA1c in type 2 diabetes: A cohort study with UK and Taiwanese cohorts.
by: Jason I Chiang, et al.
Published: (2020-05-01)

Economic opportunity: a determinant of health?
by: Srinivasa Vittal Katikireddi
Published: (2016-11-01)

Polypharmacy and deprescribing: challenging the old and embracing the new
by: Lisa Kouladjian O’Donnell, et al.
Published: (2022-09-01)

Polypharmacy in multimorbid older adults: protocol for a systematic review
by: Caroline Sirois, et al.
Published: (2017-05-01)

Polypharmacy and precision medicine
by: Kenji Fujita, et al.
Published: (2023-01-01)

Correction to: Polypharmacy and deprescribing: Challenging the old and embracing the new
by: Lisa Kouladjian O’Donnell, et al.
Published: (2022-10-01)

Multidose Drug Dispensing in Community Healthcare Settings for Patients With Multimorbidity and Polypharmacy
by: Adela Martín-Oliveros PhD Pharma, et al.
Published: (2024-10-01)

COMMUNITY PHARMACIST-PHYSICIAN COLLABORATION IN MANAGING POLYPHARMACY AND MULTIMORBIDITY IN POLAND AND PORTUGAL
by: Filipe Prazeres
Published: (2024-04-01)

Polypharmacy Patterns in Multimorbid Older People with Cardiovascular Disease: Longitudinal Study
by: Noemí Villén, et al.
Published: (2022-12-01)

Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study
by: Yong Zhao, et al.
Published: (2023-07-01)

Experiences of multimorbidity in urban and rural Malawi: An interview study of burdens of treatment and lack of treatment
by: Edith F. Chikumbu, et al.
Published: (2022-01-01)

The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function
by: Michael K. Sullivan, et al.
Published: (2022-11-01)

Exploring Public, Practitioner and Policymaker Perspectives of Unhealthy Lifestyle Factors in the Context of Socioeconomic Deprivation: A Qualitative Study
by: Hamish M. E. Foster, et al.
Published: (2024-10-01)

Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis
by: Reeve, J, et al.
Published: (2022)

Prevalence of multimorbidity and polypharmacy among adults and older adults: a systematic review
by: Kathryn Nicholson, PhD, et al.
Published: (2024-04-01)